Related Experiment Videos
Defining patients at risk for neoplastic meningitis: what parameters can be used to determine who should be treated?
Marc C Chamberlain1, Larry Junck
1USC/Norris Cancer Center, Department of Neurology, 1441 Eastlake Ave., Suite 3459, Los Angeles, CA 90033-0804, USA. chamberl@usc.edu
Expert Review of Neurotherapeutics
|April 28, 2005
Abstract:
While a growing body of clinical research is defining how better to treat neoplastic meningitis, questions regarding which parameters can be used to define who to treat remain. This discussion initiates the clinical core and practical components of the symposium.